Abstract:Alimentary Pharmacology & Therapeutics Symposium SeriesVolume 1, Issue 1 p. 26-32 Panel discussion: treatment approaches to control gastrointestinal risk and balance cardiovascular risks and benefits: proposals and recommendations J. M. SCHEIMAN, J. M. SCHEIMAN University of Michigan Medical Center, Ann Arbor, MI, USASearch for more papers by this authorB. CRYER, B. CRYER University of Texas Southwestern Medical School, Dallas VA Medical Center, Dallas, TX, USASearch for more papers by this authorM. ASAKA, M. ASAKA Hokkaido University Graduate School of Medicine, Sapporo, Hokkaido, JapanSearch for more papers by this authorF. BERENBAUM, F. BERENBAUM Faculty of Medicine Pierre and Marie Curie, Department of Rheumatology, Saint-Antoine Hospital, Paris, FranceSearch for more papers by this authorJ. BONNET, J. BONNET Cardiology and Vascular Diseases Department, Victor Segalen University, Bordeaux, FranceSearch for more papers by this authorF. K.-L. CHAN, F. K.-L. CHAN Division of Gastroenterology and Hepatology, Department of Medicine and Therapeutics, Prince of Wales Hospital, Hong Kong, ChinaSearch for more papers by this authorG. KREJS, G. KREJS Karl-Franzens University, Graz, AustriaSearch for more papers by this authorA. LANAS, A. LANAS Gastroenterology Department, HCU, Instituto Aragones de Ciencias de la Salud (Red C03/02), Zaragoza, SpainSearch for more papers by this authorA. WEAVER, A. WEAVER University of Nebraska Medical Center, Omaha, NE, USASearch for more papers by this authorF. ZERBIB, F. ZERBIB Department of Gastroenterology, Saint-Andre Hospital, Bordeaux, FranceSearch for more papers by this author J. M. SCHEIMAN, J. M. SCHEIMAN University of Michigan Medical Center, Ann Arbor, MI, USASearch for more papers by this authorB. CRYER, B. CRYER University of Texas Southwestern Medical School, Dallas VA Medical Center, Dallas, TX, USASearch for more papers by this authorM. ASAKA, M. ASAKA Hokkaido University Graduate School of Medicine, Sapporo, Hokkaido, JapanSearch for more papers by this authorF. BERENBAUM, F. BERENBAUM Faculty of Medicine Pierre and Marie Curie, Department of Rheumatology, Saint-Antoine Hospital, Paris, FranceSearch for more papers by this authorJ. BONNET, J. BONNET Cardiology and Vascular Diseases Department, Victor Segalen University, Bordeaux, FranceSearch for more papers by this authorF. K.-L. CHAN, F. K.-L. CHAN Division of Gastroenterology and Hepatology, Department of Medicine and Therapeutics, Prince of Wales Hospital, Hong Kong, ChinaSearch for more papers by this authorG. KREJS, G. KREJS Karl-Franzens University, Graz, AustriaSearch for more papers by this authorA. LANAS, A. LANAS Gastroenterology Department, HCU, Instituto Aragones de Ciencias de la Salud (Red C03/02), Zaragoza, SpainSearch for more papers by this authorA. WEAVER, A. WEAVER University of Nebraska Medical Center, Omaha, NE, USASearch for more papers by this authorF. ZERBIB, F. ZERBIB Department of Gastroenterology, Saint-Andre Hospital, Bordeaux, FranceSearch for more papers by this author First published: 26 August 2005 https://doi.org/10.1111/j.1746-6342.2005.00018.xCitations: 4Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat Citing Literature Volume1, Issue1September 2005Pages 26-32 RelatedInformation

Editorial: Gastrointestinal symptoms—A world of differences

Editorial: Diagnosis of GERD in patients with extra‐oesophageal symptoms–still a long way to go...

Editorial: The prevalence and outcomes of perianal Crohn's disease across treatment eras

Editorial: Faecal microbiota transplantation in IBS—Moving closer or away from success?

Editorial: Treatments for inflammatory bowel disease across the age‐spectrum—Are they the same?

Editorial: A Mediterranean diet for IBS—Is healthy and inclusive eating the way forward?

Editorial: Chronology of gastrointestinal cancers and gastrointestinal microbiota

Editorial: Time to address quality of life in our IBD treatment—IBD nurse intervention as a key part of multimodal IBD management

Editorial: Treatments for inflammatory bowel disease across age‐spectrum—Are they the same? Authors' reply

Editorial: The unquenchable thirst for drinks and diets as treatments for constipation

Editorial: Exclusive enteral nutrition: Positioning in the ever‐growing landscape of inflammatory bowel disease therapy

Editorial: Disorders of gut‐brain interaction—Don't forget the older person

Editorial for the Special Issue "Gut Dysbiosis: Molecular Mechanisms and Therapies 2.0"

Editorial: The prevalence and outcomes of perianal Crohn's disease across the treatment eras—Authors' reply

Editorial: Novel advances in gastrointestinal cancer treatment.

Editorial: delayed gastric emptying as an independent predictor of mortality in gastroparesis—it is clinically relevant after all!

Mechanisms underlying food-related symptoms in disorders of gut-brain interaction: Course ahead in research and clinical practice

Editorial: Eosinophilic oesophagitis coming of age—Increasing frequency and wider age range

Editorial: Eosinophilic oesophagitis coming of age—Increasing frequency and wider age range—Authors' reply

Editorial: The microbiome and gastric mucosal protection in aspirin users—Authors' reply

Panel Discussion: Treatment Approaches to Control Gastrointestinal Risk and Balance Cardiovascular Risks and Benefits: Proposals and Recommendations